Loading organizations...
Loading organizations...
Biotechnology developing drugs that cross the blood-brain barrier.
AngioChem has raised $11.5M across 2 funding rounds.
AngioChem has raised $11.5M in total across 2 funding rounds.
AngioChem has raised $11.5M in total across 2 funding rounds.
AngioChem's investors include Pierre Fitzgibbon.
AngioChem has raised $11.5M across 2 funding rounds. Most recently, it raised $4.0M Debt in June 2019.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 4, 2019 | $4.0M Debt | Pierre Fitzgibbon | |
| Aug 1, 2018 | $7.5M Series C |